Growing Need for Vaccinations Strengthens Role of Poultry Pharmaceuticals in Animal Healthcare, reports TMR The poultry pharmaceuticals market is dominated by Merck Animal Health and Zoetis Inc. and the two companies together accounted for over half the market in 2015. The rest of the market is, however, fragmented and is characterized by the presence of several large and small players. Transparency Market Research notes that the rivalry within the animal healthcare industry is quite high due to the existence of a large number of players and this trend is also reflected in the global poultry pharmaceutical market. “The high degree of competition ensures that poultry pharmaceutical companies maintain regular interaction and collaborations with drug retailers, governments, and poultry farmers,� the author of the study states. Product innovation has also proven to be a successful strategy adopted by players in the poultry pharmaceutical market, TMR finds. For instance, in September 2015, Merial Animal Health globally launched its innovation in poultry vaccination technology, known as Merial Avinew. This move has strengthened Merial’s position in the market.
Global Poultry Pharmaceuticals Market to Reach US$7.8 bn by 2024
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.